A multivariate regression analysis including data from 13 TCGA studies across multiple tumor types confirmed all of the above negative correlations between FASN expression and immune cell landscapes in breast cancer (β estimate < 0, p < 0.01), but failed to detect any positive significant associations (Table S2; Fig. S3). The gene discussed is FASN; the disease is breast carcinoma.